Connealy Pamela Yanchik Immunovant, Inc. (IMVT) insider trading activity

Connealy Pamela Yanchik is Chief Financial Officer of Immunovant, Inc.. Currently has a direct ownership of 46,200 shares of IMVT, which is worth approximately $1.27 Million. The most recent transaction as insider was on Mar 19, 2021, when has been sold 46,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.2K

0% 3M change

0% 12M change

Total Value Held $1.27 Million

Connealy Pamela Yanchik Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 19 2021	BUY Grant, award, or other acquisition	-	46,200 Added 50.0%	46,200 Common Stock

Also insider at

PYXS

Pyxis Oncology, Inc. Healthcare

CFO & COO

HSAQ

Health Sciences Acquisitions Corp 2 Financial Services

Director

CPY